Yuan-Feng Lin
Overview
Explore the profile of Yuan-Feng Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
834
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang W, Lin H, Lin C, Lee H, Chen Y, Lin Y, et al.
Breast Cancer Res
. 2024 Dec;
26(1):193.
PMID: 39741338
Background: Triple negative breast cancer (TNBC) belongs to the worst prognosis of breast cancer subtype probably because of distant metastasis to other organs, e.g. lungs. However, the mechanism underlying TNBC...
2.
Chiu H, Lin C, Lee H, Lu H, Lin Y, Lin Y, et al.
Clin Immunol
. 2024 Jan;
259:109892.
PMID: 38185269
Radioresistance and metastasis are critical issues in managing oral squamous cell carcinoma (OSCC). Although immune checkpoint inhibitors (ICIs) has been recommended to treat OSCC, lacking useful biomarkers limited their anti-cancer...
3.
Chiu H, Lee H, Lee H, Lu H, Lin K, Lin Y, et al.
J Transl Med
. 2024 Jan;
22(1):13.
PMID: 38166970
Background: Radioresistance and lymph node metastasis are common phenotypes of refractory oral squamous cell carcinoma (OSCC). As a result, understanding the mechanism for radioresistance and metastatic progression is urgently needed...
4.
Chang H, Hsu M, Chien L, Chi N, Yu M, Chen H, et al.
Cells
. 2023 Nov;
12(21).
PMID: 37947623
Increased medical attention is needed as the prevalence of autism spectrum disorder (ASD) rises. Both cardiovascular disorder (CVD) and hyperlipidemia are closely associated with adult ASD. plays a key genetic...
5.
Yuan T, Lin H, Kuei C, Lin C, Lee H, Lee H, et al.
Cancer Cell Int
. 2023 Mar;
23(1):41.
PMID: 36890567
Background: Radiotherapy is the first-line regimen for treating oral squamous cell carcinoma (OSCC) in current clinics. However, the development of therapeutic resistance impacts the anticancer efficacy of irradiation in a...
6.
Zheng J, Lin C, Lee H, Chang W, Li L, Su C, et al.
Cancer Sci
. 2022 Sep;
114(1):306-320.
PMID: 36104978
Cancer metastasis leading to the dysfunction of invaded organs is the main cause of the reduced survival rates in lung cancer patients. However, the molecular mechanism for lung cancer metastasis...
7.
Zheng J, Lin C, Lee H, Wang W, Tong Y, Lee K, et al.
Biomedicines
. 2021 Dec;
9(12).
PMID: 34944711
Approximately 30% of clear cell renal cell carcinoma (ccRCC) patients develop metastatic spread at the first diagnosis. Therefore, identifying a useful biomarker to predict ccRCC metastasis or therapeutic effectiveness in...
8.
Lee T, Liu H, Lin Y, Lee T, Kao Y, Chen Y
Med Hypotheses
. 2021 Nov;
158:110724.
PMID: 34753007
Sarcopenia, the age-associated-fragility with loss of skeletal muscle mass and function, often coexists with type 2 diabetes (T2D) in older individuals. Derangement of muscle metabolism and mitochondrial dynamics is critical,...
9.
Huang S, Li C, Chang W, Lin Y
Biology (Basel)
. 2021 Aug;
10(8).
PMID: 34439934
Although several biomarkers have been identified to predict the prognosis of lower-grade (Grade II/III) gliomas (LGGs), we still need to identify new markers to facilitate those well-known markers to obtain...
10.
Zheng J, Lin C, Chen C, Lin Y, Chiu C, Yang T, et al.
J Clin Med
. 2021 Aug;
10(15).
PMID: 34362218
Type 2 diabetes mellitus (DM) patients are at a higher risk for developing lung cancer due to immune dysfunction and chronic inflammation. They also have increased morbidity and mortality related...